• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于基因表达筛选血小板衍生生长因子受体(PDGFR)信号传导抑制剂

Gene expression-based screening for inhibitors of PDGFR signaling.

作者信息

Antipova Alena A, Stockwell Brent R, Golub Todd R

机构信息

Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge Center, Cambridge, MA 02142, USA.

出版信息

Genome Biol. 2008;9(3):R47. doi: 10.1186/gb-2008-9-3-r47. Epub 2008 Mar 1.

DOI:10.1186/gb-2008-9-3-r47
PMID:18312689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2397499/
Abstract

Here we describe a proof-of-concept experiment designed to explore the possibility of using gene expression-based high-throughput screening (GE-HTS) to find inhibitors of a signaling cascade, using platelet derived growth factor receptor (PDGFR) signaling as the example. The previously unrecognized ability of aurintricarboxylic acid to inhibit PDGFR signaling, discovered through a screen of 1,739 compounds, demonstrates the feasibility and generalizability of GE-HTS for the discovery of small molecule modulators of any signaling pathway of interest.

摘要

在此我们描述了一项概念验证实验,该实验旨在探索利用基于基因表达的高通量筛选(GE-HTS)来寻找信号级联反应抑制剂的可能性,以血小板衍生生长因子受体(PDGFR)信号传导为例。通过对1739种化合物的筛选发现,金精三羧酸具有此前未被认识到的抑制PDGFR信号传导的能力,这证明了GE-HTS用于发现任何感兴趣信号通路的小分子调节剂的可行性和通用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/73d46aa08f79/gb-2008-9-3-r47-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/7f7e5b63f73e/gb-2008-9-3-r47-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/1822efe63ca1/gb-2008-9-3-r47-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/1b6ab238c225/gb-2008-9-3-r47-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/bed4ca3862a5/gb-2008-9-3-r47-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/a99659c2af7c/gb-2008-9-3-r47-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/84d604d129e0/gb-2008-9-3-r47-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/eaed96d714f1/gb-2008-9-3-r47-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/efba873653c3/gb-2008-9-3-r47-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/73d46aa08f79/gb-2008-9-3-r47-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/7f7e5b63f73e/gb-2008-9-3-r47-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/1822efe63ca1/gb-2008-9-3-r47-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/1b6ab238c225/gb-2008-9-3-r47-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/bed4ca3862a5/gb-2008-9-3-r47-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/a99659c2af7c/gb-2008-9-3-r47-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/84d604d129e0/gb-2008-9-3-r47-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/eaed96d714f1/gb-2008-9-3-r47-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/efba873653c3/gb-2008-9-3-r47-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ec6/2397499/73d46aa08f79/gb-2008-9-3-r47-9.jpg

相似文献

1
Gene expression-based screening for inhibitors of PDGFR signaling.基于基因表达筛选血小板衍生生长因子受体(PDGFR)信号传导抑制剂
Genome Biol. 2008;9(3):R47. doi: 10.1186/gb-2008-9-3-r47. Epub 2008 Mar 1.
2
Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency.血小板衍生生长因子受体信号的抑制调节 Oct4 和 Nanog 的表达、细胞形态和间充质干细胞的潜能。
Stem Cells. 2012 Mar;30(3):548-60. doi: 10.1002/stem.1015.
3
Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.产后肌腱生长和重塑需要血小板衍生生长因子受体信号。
Am J Physiol Cell Physiol. 2018 Apr 1;314(4):C389-C403. doi: 10.1152/ajpcell.00258.2017. Epub 2017 Dec 13.
4
Identification of novel FLT3 kinase inhibitors.鉴定新型 FLT3 激酶抑制剂。
Eur J Med Chem. 2013 May;63:713-21. doi: 10.1016/j.ejmech.2013.03.024. Epub 2013 Mar 21.
5
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.MEK1/2 与 PI3K 或 PDGFR 的联合激酶抑制剂在颅内三阴性乳腺癌中有效。
Neuro Oncol. 2017 Oct 19;19(11):1481-1493. doi: 10.1093/neuonc/nox052.
6
Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.选择性血小板衍生生长因子受体(PDGFR)酪氨酸激酶抑制剂CP-673,451的抗血管生成及抗肿瘤活性
Cancer Res. 2005 Feb 1;65(3):957-66.
7
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.血小板衍生生长因子受体在前列腺癌中的表达及酪氨酸激酶抑制剂的治疗意义
Neoplasia. 2004 Sep-Oct;6(5):503-12. doi: 10.1593/neo.04157.
8
Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.番泻苷B抑制人骨肉瘤细胞中血小板衍生生长因子受体信号传导以及血小板衍生生长因子BB诱导的细胞增殖。
Life Sci. 2009 Jun 19;84(25-26):915-22. doi: 10.1016/j.lfs.2009.04.003. Epub 2009 Apr 22.
9
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.血小板衍生生长因子受体α在乳腺癌中的过表达与肿瘤进展相关。
Breast Cancer Res. 2005;7(5):R788-95. doi: 10.1186/bcr1304. Epub 2005 Aug 1.
10
Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance.与抗癌药物耐药性相关的受体酪氨酸激酶EGFR和PDGFR-β新型双重抑制剂的发现。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1-8. doi: 10.1080/14756366.2017.1370583.

引用本文的文献

1
Convolutional neural network for biomarker discovery for triple negative breast cancer with RNA sequencing data.利用RNA测序数据发现三阴性乳腺癌生物标志物的卷积神经网络
Heliyon. 2023 Mar 23;9(4):e14819. doi: 10.1016/j.heliyon.2023.e14819. eCollection 2023 Apr.
2
A Gene Expression High-Throughput Screen (GE-HTS) for Coordinated Detection of Functionally Similar Effectors in Cancer.一种用于协同检测癌症中功能相似效应物的基因表达高通量筛选(GE-HTS)
Cancers (Basel). 2020 Oct 27;12(11):3143. doi: 10.3390/cancers12113143.
3
Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.

本文引用的文献

1
Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.基于特征的小分子筛选确定阿糖胞苷为尤因肉瘤中EWS/FLI的调节剂。
PLoS Med. 2007 Apr;4(4):e122. doi: 10.1371/journal.pmed.0040122.
2
Protein kinases as drug targets in cancer.蛋白激酶作为癌症治疗的药物靶点。
Curr Cancer Drug Targets. 2006 Nov;6(7):623-34. doi: 10.2174/156800906778742479.
3
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.基于基因表达特征的化学基因组预测鉴定出一类新型的HSP90途径调节剂。
替米沙坦通过阻断 AT1 受体或激活 PPARγ以外的机制来保护小胶质细胞系免受 LPS 损伤。
Mol Neurobiol. 2019 May;56(5):3193-3210. doi: 10.1007/s12035-018-1300-9. Epub 2018 Aug 13.
4
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.金精三羧酸作为胶质母细胞瘤细胞中TWEAK-Fn14信号通路的选择性抑制剂的鉴定。
Oncotarget. 2017 Feb 14;8(7):12234-12246. doi: 10.18632/oncotarget.14685.
5
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation.小分子蛋白质稳态调节剂,可重新编程内质网以减少细胞外蛋白质聚集。
Elife. 2016 Jul 20;5:e15550. doi: 10.7554/eLife.15550.
6
KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.KSR1和EPHB4调节Myc和PGC1β以促进人类结肠肿瘤的存活。
Mol Cell Biol. 2016 Aug 12;36(17):2246-61. doi: 10.1128/MCB.00087-16. Print 2016 Sep 1.
7
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures.LINCS Canvas 浏览器:交互式网络应用程序,用于查询、浏览和分析 LINCS L1000 基因表达特征。
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W449-60. doi: 10.1093/nar/gku476. Epub 2014 Jun 6.
8
High-throughput library screening identifies two novel NQO1 inducers in human lung cells.高通量文库筛选鉴定出人肺细胞中两种新型 NQO1 诱导剂。
Am J Respir Cell Mol Biol. 2012 Mar;46(3):365-71. doi: 10.1165/rcmb.2011-0301OC. Epub 2011 Oct 20.
9
High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation.通过邻近连接技术对原代细胞中蛋白质相互作用和翻译后修饰的抑制剂进行高通量筛选。
Mol Cell Proteomics. 2010 Jan;9(1):178-83. doi: 10.1074/mcp.M900331-MCP200. Epub 2009 Oct 27.
10
Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells.对血小板衍生生长因子受体(PDGFR)基因定义细胞中PDGF-PDGFR信号通路的全面剖析。
PLoS One. 2008;3(11):e3794. doi: 10.1371/journal.pone.0003794. Epub 2008 Nov 24.
Cancer Cell. 2006 Oct;10(4):321-30. doi: 10.1016/j.ccr.2006.09.005. Epub 2006 Sep 28.
4
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.基于基因表达的化学基因组学鉴定出雷帕霉素是MCL1和糖皮质激素抗性的调节剂。
Cancer Cell. 2006 Oct;10(4):331-42. doi: 10.1016/j.ccr.2006.09.006. Epub 2006 Sep 28.
5
A method for high-throughput gene expression signature analysis.一种用于高通量基因表达特征分析的方法。
Genome Biol. 2006;7(7):R61. doi: 10.1186/gb-2006-7-7-r61.
6
Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol-1,4,5-trisphosphate 3-kinases and inositol polyphosphate multikinase.具有抗增殖作用的植物多酚和合成多酚是脊椎动物肌醇-1,4,5-三磷酸3-激酶和肌醇多磷酸多激酶的特异性抑制剂。
J Biol Chem. 2005 Apr 8;280(14):13229-40. doi: 10.1074/jbc.M500545200. Epub 2005 Jan 19.
7
Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens.用于基于哺乳动物细胞筛选的、嵌入可生物降解聚合物中的小分子微阵列。
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16144-9. doi: 10.1073/pnas.0404425101. Epub 2004 Nov 8.
8
Aurintricarboxylic acid translocates across the plasma membrane, inhibits protein tyrosine phosphatase and prevents apoptosis in PC12 cells.金精三羧酸穿过质膜,抑制蛋白酪氨酸磷酸酶并防止PC12细胞凋亡。
Mol Cells. 2004 Aug 31;18(1):46-52.
9
Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation.基于基因表达的高通量筛选(GE-HTS)及其在白血病分化中的应用。
Nat Genet. 2004 Mar;36(3):257-63. doi: 10.1038/ng1305. Epub 2004 Feb 8.
10
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.JAK/STAT、Raf/MEK/ERK、PI3K/Akt和BCR-ABL在细胞周期进程和白血病发生中的作用。
Leukemia. 2004 Feb;18(2):189-218. doi: 10.1038/sj.leu.2403241.